Related Experiment Video

Updated: Jun 1, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Chronic granulomatous disease: a review of the infectious and inflammatory complications

Eunkyung Song1, Gayatri Bala Jaishankar, Hana Saleh

  • 1Department of Pediatrics, Division of Allergy and Clinical Immunology, Quillen College of Medicine, East Tennessee State University, USA. krishnas@etsu.edu.

Clinical and Molecular Allergy : CMA
|June 1, 2011
PubMed

Insights

Chronic Granulomatous Disease (CGD) is an immunodeficiency where phagocytes cannot produce superoxide, leading to recurrent infections. Advances in diagnosis and treatment offer hope, with gene therapy and stem cell transplantation on the horizon.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Chronic Granulomatous Disease (CGD) is a primary immunodeficiency affecting phagocyte function.
  • It is characterized by recurrent, severe bacterial and fungal infections and granuloma formation.
  • CGD results from a defect in the NADPH oxidase system, impairing superoxide generation.

Purpose of the Study:

  • To provide an overview of Chronic Granulomatous Disease.
  • To highlight the pathophysiology, clinical manifestations, and treatment advances.
  • To discuss future therapeutic potentials like gene therapy and stem cell transplantation.

Main Methods:

  • Literature review of Chronic Granulomatous Disease.
  • Analysis of diagnostic criteria and treatment strategies.
  • Examination of current research on novel therapies.

Main Results:

  • CGD patients are susceptible to infections from Staphylococcus aureus, Pseudomonas, Nocardia, Aspergillus, and Candida.
  • Organ involvement can lead to significant morbidity and mortality.
  • Significant progress has been made in managing CGD.

Conclusions:

  • Early diagnosis and appropriate management are crucial for improving outcomes in CGD.
  • Gene therapy and stem cell transplantation represent promising future directions for curative treatment.
  • Continued research is essential for advancing the care of patients with CGD.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...